We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.49 | -1.65% | 29.26 | 29.25 | 29.52 | 29.73 | 29.20 | 29.71 | 6,646,430 | 22:20:00 |
From May 2019 to May 2024
By Donato Paolo Mancini
Roche Holding AG (ROG.EB) on Thursday raised its 2018 sales outlook after first-quarter sales increased.
The Basel-based company said its sales rose to 13.6 billion Swiss francs ($13.8 billion) from CHF12.9 billion, beating expectations. According to a FactSet consensus estimate, Roche was forecast to post sales for EUR13.35 billion.
Sales are expected to grow at a low single-digit rate in the full year, the company said. The pharmaceutical company had previously forecast that sales would be stable compared to 2017 or rise by a low single-digit percentage.
The company also said it expects to further increase its dividend in Swiss francs.
Write to Donato Paolo Mancini at donatopaolo.mancini@dowjones.com
(END) Dow Jones Newswires
April 26, 2018 01:34 ET (05:34 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
